Patent row between pharma companies referred to European court
Clonmel and Merck in dispute over combination of ingredients in cholesterol drug
Pharma patent appeals dismissed by Court of Appeal
Case involved Clonmel Healthcare and Merck Sharp and Dohme
Medicines supply in Ireland ‘could be destabilised’ by EU stance on North protocol
Pharma bodies call on EU Commission to introduce a four-year derogation on application of protocol
Irish pharmaceutical maker succeeds in case against MSD in patent rights row
Clonmel Healthcare claimed combination of two active ingredients of Ezetimibe and Simvastin not protected by underlying patent
Patients using drug recalled over impurity urged not to panic
About 50,000 Irish patients likely to be affected by recall of drugs containing valsartan
Drugs recalled over impurity classed as ‘probable carcinogen’
About 50,000 Irish patients believed to be affected by move on some heart products containing valsartan
Court refuses Merck injunction against Clonmel Healthcare
Dispute is over Clonmel’s generic alternative to cholesterol drug ‘Inegy’
Merck appeals refusal to continue injunction against Clonmel Healthcare
Judgment likely to be given in June
Sale of rival MSD cholesterol drug breaching patent rights, court told
Clonmel Healthcare launched generic version of MSD cholesterol drug last week
Alliance of generic drug makers warns supply reforms needed
Group claims patients may face increasing difficulty accessing lifesaving medicines
Southeast embraces mobile data applications
Improved connectivity will allow regional businesses to use hand-held devices to access resources remotely
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices